Hepatorenal Syndrome Global Clinical Trials Review, H2, 2017

  • ID: 4413708
  • Clinical Trials
  • Region: Global
  • 57 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Ferring Holding SA
  • JSS Medical Research Inc
  • Mallinckrodt Plc
  • Novartis AG
  • Orphan Therapeutics LLC
  • MORE
Hepatorenal Syndrome Global Clinical Trials Review, H2, 2017

Summary

The clinical trial report, “Hepatorenal Syndrome Global Clinical Trials Review, H2, 2017" provides an overview of Hepatorenal Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatorenal Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using the author’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Ferring Holding SA
  • JSS Medical Research Inc
  • Mallinckrodt Plc
  • Novartis AG
  • Orphan Therapeutics LLC
  • MORE
  • Report Guidance
  • Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Hepatorenal Syndrome Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Hepatorenal Syndrome
  • Jul 13, 2017: Mallinckrodt Phase 3 Terlipressin Trial Achieves its Enrollment Target Ahead of Schedule
  • Jun 23, 2017: Health Economic Data on Burden of Hepatorenal Syndrome Published in Current Medical Research and Opinion
  • Clinical Trial Profile Snapshots
  • Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About
  • Contact
  • Source
List of Tables
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Region, 2017*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2017*
  • Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, G7 Countries (%), 2017*
  • Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
  • Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
  • Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, E7 Countries (%), 2017*
  • Hepatorenal Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
  • Hepatorenal Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Phase, 2017*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2017*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
  • Hepatorenal Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*
List of Figures
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2017*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2017*
  • Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, G7 Countries (%), 2017*
  • Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
  • Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
  • Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, E7 Countries (%), 2017*
  • Hepatorenal Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
  • Hepatorenal Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2017*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2017*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
  • Hepatorenal Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*
  • Methodology
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Mallinckrodt Plc
  • Ferring Holding SA
  • La Jolla Pharmaceutical Company
  • Orphan Therapeutics LLC
  • Novartis AG
  • Noorik Biopharmaceuticals AG
  • JSS Medical Research Inc
  • European Association for the Study of the Liver
  • Cumberland Pharmaceuticals Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll